Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of Alzheimer’s disease. | The two plasma-based, in vitro tests scan for specific proteins linked to changes in the brain to help rule out the chances of Alzheimer’s among people showing cognitive decline.
Experts from Which? have warned that four unexpected devices could be spying on you.
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the…
Health policies that hang in the Election Day balance. Plus, abortion measures, Medicare payment rates, vaccines, PPE, and more
Reuploaded 11/2/2024 with a corrected typo.In most countries, health care systems negotiate drug prices directly with pharmaceutical companies, making crucia…
Experimentation with cannabis during adolescence may reduce the brain’s capacity for new information.
The Supreme Court will hear arguments Tuesday on a lawsuit challenging how the government calculates Medicare disproportionate share hospital payments.
This cohort study of US emergency departments examines the cost effectiveness of high readiness for pediatric cases, estimating costs and lives saved by maintaining universal…
Researchers looking for sustainable materials with optimal mechanical properties may draw inspiration from a baseball tradition. For nearly 100 y, …
The functional consequences and disease relevance of most DNA variants found in human genomes are unknown. Here, Cooper et al. review CRISPR-based gene editing approaches that…
